Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MDWD

+ Watchlist+ Portfolio

MediWound Ltd.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$13.68
52-Week Range
$11.80 – $19.70
Market Cap
$195.85M
P/E (TTM)
—
EPS (TTM)
-2.57
Dividend Yield
0.00%
Advanced Metrics
Price/Book
5.55
PEG Ratio
—
Return on Equity
-57.39%
Return on Assets
-26.41%
Gross Margin
19.54%
Operating Margin
-337.63%
Profit Margin
-234.98%
Current Ratio
2.23
Debt/Equity
0.26
Total Debt
$8.30M
Free Cash Flow
$-30.72M
Revenue Growth
-34.20%
Earnings Growth
—
Enterprise Value
$156.95M

Market Snapshot

About

MediWound Ltd. is an Israeli biopharmaceutical company specializing in the development, manufacturing, and commercialization of enzymatic therapeutics for severe burns, chronic wounds, and other hard-to-heal wounds. The company markets NexoBrid for burn wound debridement and EscharEx for chronic wound treatment.